FormulaFolio Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-19,836
Closed -$693K 692
2020
Q4
$693K Buy
19,836
+11,298
+132% +$391K 0.01% 389
2020
Q3
$296K Hold
8,538
0.01% 258
2020
Q2
$280K Sell
8,538
-150
-2% -$4.79K 0.01% 244
2020
Q1
$262K Sell
8,688
-736
-8% -$21.9K 0.01% 233
2019
Q4
$273K Buy
9,424
+1,192
+14% +$33K 0.01% 319
2019
Q3
$213K Sell
8,232
-62
-0.7% -$1.57K 0.01% 321
2019
Q2
$212K Sell
8,294
-160
-2% -$3.95K 0.01% 301
2019
Q1
$221K Sell
8,454
-964
-10% -$23.7K 0.01% 306
2018
Q4
$222K Hold
9,418
0.01% 296
2018
Q3
$222K Sell
9,418
-220
-2% -$5.37K 0.01% 296
2018
Q2
$222K Buy
9,638
+2
+0% +$48 0.01% 281
2018
Q1
$237K Sell
9,636
-7,140
-43% -$187K 0.01% 245
2017
Q4
$450K Buy
16,776
+802
+5% +$20.4K 0.03% 176
2017
Q3
$385K Buy
15,974
+2
+0% +$45 0.03% 164
2017
Q2
$343K Sell
15,972
-120
-0.7% -$2.42K 0.03% 160
2017
Q1
$276K Buy
+16,092
New +$280K 0.03% 170

Other funds holding NVO

FormulaFolio Investments's NVO Position: Q1 2021 in Review

FormulaFolio Investments sold out of Novo Nordisk (NVO) in Q1 2021, closing a stake of 19,836 shares — an estimated $693K sold.

FormulaFolio Investments first reported a position in NVO in Q1 2017 and held it in 16 quarters. The position peaked at $693K in Q4 2020. 707 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

  • FormulaFolio Investments reported no remaining Novo Nordisk position as of Q1 2021 after selling out during the quarter.
  • FormulaFolio Investments sold 19,836 Novo Nordisk shares in Q1 2021, an estimated $693K.
  • FormulaFolio Investments first reported a position in Novo Nordisk in Q1 2017 and held it in 16 quarters.
  • FormulaFolio Investments's Novo Nordisk position peaked at $693K in Q4 2020.
  • 707 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on FormulaFolio Investments's 13F filing for Q1 2021, filed 28 May 2021.